JP2001512319A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001512319A5 JP2001512319A5 JP1998536013A JP53601398A JP2001512319A5 JP 2001512319 A5 JP2001512319 A5 JP 2001512319A5 JP 1998536013 A JP1998536013 A JP 1998536013A JP 53601398 A JP53601398 A JP 53601398A JP 2001512319 A5 JP2001512319 A5 JP 2001512319A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/802,322 US5932425A (en) | 1997-02-18 | 1997-02-18 | Compositions and methods for modulating cellular NF-κB activation |
| US08/802,322 | 1997-02-18 | ||
| PCT/US1998/003163 WO1998036070A1 (en) | 1997-02-18 | 1998-02-18 | COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-λB ACTIVATION |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009255576A Division JP2010063461A (ja) | 1997-02-18 | 2009-11-06 | 細胞のＮＦ−κＢ活性化を調節するための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001512319A JP2001512319A (ja) | 2001-08-21 |
| JP2001512319A5 true JP2001512319A5 (https=) | 2005-10-06 |
| JP4560616B2 JP4560616B2 (ja) | 2010-10-13 |
Family
ID=25183386
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53601398A Expired - Fee Related JP4560616B2 (ja) | 1997-02-18 | 1998-02-18 | 細胞のＮＦ−κＢ活性化を調節するための組成物および方法 |
| JP2009255576A Withdrawn JP2010063461A (ja) | 1997-02-18 | 2009-11-06 | 細胞のＮＦ−κＢ活性化を調節するための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009255576A Withdrawn JP2010063461A (ja) | 1997-02-18 | 2009-11-06 | 細胞のＮＦ−κＢ活性化を調節するための組成物および方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5932425A (https=) |
| EP (1) | EP1009824B1 (https=) |
| JP (2) | JP4560616B2 (https=) |
| AT (1) | ATE391177T1 (https=) |
| AU (1) | AU6659198A (https=) |
| CA (1) | CA2281920C (https=) |
| DE (1) | DE69839326T2 (https=) |
| WO (1) | WO1998036070A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0920518A1 (en) * | 1996-08-26 | 1999-06-09 | Signal Pharmaceuticals, Inc. | Stimulus-inducible i (kappa)b kinase ikk] signalsome |
| US6896899B2 (en) * | 1996-12-31 | 2005-05-24 | Antioxidant Pharmaceuticals Corp. | Pharmaceutical preparations of glutathione and methods of administration thereof |
| DE69739663D1 (de) | 1996-12-31 | 2009-12-31 | Antioxidant Pharmaceuticals Co | Pharmazeutische glutathionpräparate und methoden zu dern verabreichung |
| WO1999066065A2 (en) * | 1998-06-13 | 1999-12-23 | Zarpex Biosciences Limited | Proteasomal activity |
| ES2361660T3 (es) | 1998-12-10 | 2011-06-21 | Signal Pharmaceuticals Llc | Ubicutina-ligasa e3 humana para la modulación de nk-kappa b. |
| US6630312B2 (en) | 1999-08-10 | 2003-10-07 | Joslin Diabetes Center, Inc. | Method for identifying compounds for treatment of insulin resistance |
| US6468755B1 (en) | 1999-08-10 | 2002-10-22 | Joslin Diabetes Center, Inc. | Method for identifying compounds for treatment of insulin resistance |
| US20030104622A1 (en) * | 1999-09-01 | 2003-06-05 | Robbins Paul D. | Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses |
| FR2801902B1 (fr) * | 1999-12-01 | 2005-03-04 | Centre Nat Rech Scient | Procedes de criblages fonctionnels d'agents aptes a moduler l'activite des complexes ubiquitine-ligases scf et leurs applications |
| WO2001079555A2 (en) | 2000-04-14 | 2001-10-25 | Millennium Pharmaceuticals, Inc. | Roles of jak/stat family members in tolerance induction |
| US20030044852A1 (en) * | 2000-08-10 | 2003-03-06 | Joslin Diabetes Center, Inc., A Massachusetts Corporation | Methods for treatment of insulin resistance |
| US20060287337A1 (en) * | 2001-11-09 | 2006-12-21 | Proteologics, Inc. | Trans-golgi network-associated processes, methods and compositions related thereto |
| AU2002349784A1 (en) * | 2001-12-03 | 2003-06-17 | Asahi Kasei Pharma Corporation | Nf-kappab activating genes |
| FR2859733A1 (fr) * | 2003-09-15 | 2005-03-18 | Centre Nat Rech Scient | Procede de criblage fonctionnel d'agents aptes a moduler l'activite des ubiquitine hydrolases et leurs applications |
| HUE034446T2 (en) * | 2004-03-02 | 2018-02-28 | Procter & Gamble | Method for binding high internal phase emulsions (HIPE) |
| FR2867783B1 (fr) * | 2004-03-16 | 2008-02-01 | Cytomics Systems | Procede de criblage d'agent modulant l'ubiquitination de la proteine ikbalpha et moyens destines a la mise en oeuvre dudit procede |
| US20070060537A1 (en) * | 2005-04-28 | 2007-03-15 | Proteologics, Inc. | Methods and compositions for inhibiting viral infections |
| US20100292306A1 (en) * | 2005-05-24 | 2010-11-18 | Carlson C George | Compositions And Methods For The Treatment Of Muscular Dystrophy |
| US20070202593A1 (en) * | 2006-02-27 | 2007-08-30 | Research Development Foundation | Cell-Targeted IKB and Methods for the Use Thereof |
| TW200902025A (en) * | 2007-04-11 | 2009-01-16 | Alcon Res Ltd | Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| US20090182035A1 (en) * | 2007-04-11 | 2009-07-16 | Alcon Research, Ltd. | Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis |
| WO2010044892A1 (en) * | 2008-10-17 | 2010-04-22 | President And Fellows Of Harvard College | Diagnostic method based on large scale identification of post-translational modification of proteins |
| US20110082145A1 (en) * | 2009-10-01 | 2011-04-07 | Alcon Research, Ltd. | Olopatadine compositions and uses thereof |
| NZ777336A (en) | 2018-12-28 | 2026-02-27 | Regeneron Pharma | Treatment of respiratory disorders with arachidonate 15-lipoxygenase (alox15) inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5122463A (en) * | 1990-05-17 | 1992-06-16 | Massachusetts Institute Of Technology | Methods for trans-destabilization of specific proteins in vivo and dna molecules useful therefor |
| EP0905236A1 (en) * | 1992-10-29 | 1999-03-31 | Medical Research Council | Transcription factor DP-1 |
| DE4243770A1 (de) * | 1992-12-23 | 1994-06-30 | Behringwerke Ag | Verfahren zur Herstellung von rekombinanten und synthetischen Peptiden und deren Verwendung |
| IL114615A0 (en) * | 1995-07-16 | 1995-11-27 | Yeda Res & Dev | Modulators of the function of fas receptors and other proteins |
| JPH11509085A (ja) * | 1995-06-23 | 1999-08-17 | テュラリク インコーポレイテッド | インターロイキン−１レセプター関連プロテインキナーゼ及び検定 |
| EP0920518A1 (en) * | 1996-08-26 | 1999-06-09 | Signal Pharmaceuticals, Inc. | Stimulus-inducible i (kappa)b kinase ikk] signalsome |
-
1997
- 1997-02-18 US US08/802,322 patent/US5932425A/en not_active Expired - Lifetime
-
1998
- 1998-02-18 WO PCT/US1998/003163 patent/WO1998036070A1/en not_active Ceased
- 1998-02-18 CA CA2281920A patent/CA2281920C/en not_active Expired - Fee Related
- 1998-02-18 EP EP98908593A patent/EP1009824B1/en not_active Expired - Lifetime
- 1998-02-18 AT AT98908593T patent/ATE391177T1/de not_active IP Right Cessation
- 1998-02-18 DE DE69839326T patent/DE69839326T2/de not_active Expired - Lifetime
- 1998-02-18 JP JP53601398A patent/JP4560616B2/ja not_active Expired - Fee Related
- 1998-02-18 AU AU66591/98A patent/AU6659198A/en not_active Abandoned
-
2009
- 2009-11-06 JP JP2009255576A patent/JP2010063461A/ja not_active Withdrawn